Article
Effect of the C-reactive protein gene on risk and clinical characteristics of schizophrenia in winter-born individuals.
European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology - 1 Jun 2020
Alfimova Margarita V, Lezheiko Tatyana V, Smirnova Svetlana V, Gabaeva Marina V, Golimbet Vera V
Abstract excerpt
C-reactive protein (CRP) levels are elevated in a subset of schizophrenia patients and correlated with more severe symptoms, which makes CRP a potential theranostic biomarker for the disease. However, genotypes associated with higher CRP concentrations have the protective effect against schizophrenia. To resolve this discrepancy, more research on the role of CRP in schizophrenia is needed. The present study aimed...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
